A Bad Day for Spectrum Pharmaceuticals' Good News
Spectrum gets a drug approved, and then the share price drops.
Monday’s Top Biotech Stories: Spectrum, Bristol-Myers Squibb, GSK, and Theravance
Spectrum, Bristol-Myers Squibb, GSK, and Theravance are the top biotech stocks to watch this morning.
This Week in Biotech: Allergan Three-Peats in a Bad Way While Agenus Impresses
An early FDA approval, an inhaled therapy being turned away by regulators for a third time, and three positive clinical updates are this week's top biotech stories.
3 Biotech Stocks with Catalysts Incoming: Spectrum, Orexigen, and Avanir
For companies involved in the development of drugs, a PDUFA decision will meaningfully impact their stocks. With this in mind, there are several PDUFA decisions in upcoming months to watch for.